cached image

Laurence Jay Korn, PhD, Stanford University

Affiliations: 
Protein Design Laboratories, Osseo, MN, United States 
Area:
http://www.walkersresearch.com/profilePages/Show_Executive_Title/Executiveprofile/L/Laurence_J_Korn_100005984.html
Website:
http://www.forbes.com/finance/mktguideapps/personinfo/FromPersonIdPersonTearsheet.jhtml?passedPersonId=902906
Google:
"Laurence Korn"
Bio:

Laurence Jay Korn, Ph.D., co-founder of PDL Biopharma, was elected as one of the Company's first directors in July 1986. Since 2004, Dr. Korn has served as an independent consultant, and also serves on the Board of Directors of Symphogen A/S, a privately held entity. Dr. Korn served as our Chairperson of the Board between July 1986 and May 2002 and as our Chairman of the Board between May 2002 and June 2004. Dr. Korn also served as our Chief Executive Officer from January 1987 until April 2002. From March 1981 to December 1986, Dr. Korn headed a research laboratory and served on the faculty of the Department of Genetics at the Stanford University School of Medicine. Dr. Korn received his Ph.D. from Stanford University and was a Helen Hay Whitney Postdoctoral Fellow at the Carnegie Institution of Washington and a Staff Scientist at the MRC Laboratory of Molecular Biology in Cambridge, England, before becoming an Assistant Professor at Stanford.

(Show more)

Mean distance: 106866 (cluster 28)
 
SNBCP
Cross-listing: Chemistry Tree

BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Tso JY, Siebel C, Korn LJ. (1989) Expression of functional Xenopus TFIIIA in Escherichia coli. Nucleic Acids Research. 17: 2145
Matsumoto Y, Korn LJ. (1988) Upstream sequences required for transcription of the TFIIIA gene in Xenopus oocytes. Nucleic Acids Research. 16: 3801-14
Tsurushita N, Maki H, Korn LJ. (1988) Site-directed mutagenesis with Escherichia coli DNA polymerase III holoenzyme. Gene. 62: 135-9
Tsurushita N, Ho L, Korn LJ. (1988) Nuclear factors in B lymphoma enhance splicing of mouse membrane-bound mu mRNA in Xenopus oocytes. Science (New York, N.Y.). 239: 494-7
Korn LJ, Siebel CW, McCormick F, et al. (1987) Ras p21 as a potential mediator of insulin action in Xenopus oocytes. Science (New York, N.Y.). 236: 840-3
Tsurushita N, Korn LJ. (1987) Effects of intron length on differential processing of mouse mu heavy-chain mRNA. Molecular and Cellular Biology. 7: 2602-5
Tsurushita N, Avdalovic NM, Korn LJ. (1987) Regulation of differential processing of mouse immunoglobulin μ heavy-chain mRNA Nucleic Acids Research. 15: 4603-4615
Tso JY, Van Den Berg DJ, Korn LJ. (1986) Structure of the gene for Xenopus transcription factor TFIIIA. Nucleic Acids Research. 14: 2187-200
Guinta DR, Tso JY, Narayanswami S, et al. (1986) Early replication and expression of oocyte-type 5S RNA genes in a Xenopus somatic cell line carrying a translocation. Proceedings of the National Academy of Sciences of the United States of America. 83: 5150-4
Morgan DO, Ho L, Korn LJ, et al. (1986) Insulin action is blocked by a monoclonal antibody that inhibits the insulin receptor kinase. Proceedings of the National Academy of Sciences of the United States of America. 83: 328-32
See more...